Ischemic Cholangiopathy clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
Seladelpar in Adult Liver Transplant Recipients With Ischemic Cholangiopathy (SELIC).
Sorry, not yet accepting patients
A prospective, open-label, single-arm, investigator-initiated study (SELIC) to evaluate the efficacy and safety of seladelpar in adult liver transplant recipients with Ischemic cholangiopathy (IC).
Last updated: